Results 51 to 60 of about 10,548 (182)

Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs

Artificial Organs, EarlyView.
This work presents a methodology for determining online‐capable hemolysis models for continuous‐flow LVADs, derived from in vitro trials. The models are based on fitting a modified power law and applying the Lagrangian approach. They assist clinicians in selecting treatment strategies that minimize hemolysis, as demonstrated with the Sputnik1 LVAD ...
Patrick Borchers, Steffen Leonhardt, Marian Walter   +2 more
wiley   +1 more source

AI‐Assisted Decision‐Making for End‐Stage Organ Failure: Opportunities and Ethical Concerns

Artificial Organs, EarlyView.
Artificial intelligence (AI) can help physicians make better decisions for people with serious organ problems by analyzing medical data to predict outcomes. Patients want AI to support, not replace, personal care from doctors. Collaboration among experts ensures AI tools respect patient values and privacy.
John W. Haller, Olga D. Brazhnik, Kathleen N. Fenton   +2 more
wiley   +1 more source

Clinical Images: Biopsy‐proven hydroxychloroquine‐induced cardiomyopathy in an adolescent with systemic lupus erythematosus

Arthritis &Rheumatology, EarlyView.
Greta Mastrangelo, Deborah M. Levy, Anita Nagy, Aamir Jeewa   +3 more
wiley   +1 more source

Follow‐Up of Left‐Ventricular Assist Device Patients With Telemonitoring: A National Retrospective Multicentric Study on the Satelia LVAD Web Application

Artificial Organs, EarlyView.
We evaluated the usefulness of remote monitoring for advanced heart failure patients using left‐ventricular assist devices (LVADs) in France. A national, retrospective study on a web application (Satelia) at nine locations was conducted. Specialized remote monitoring could facilitate LVAD follow‐ups and improve outcomes.
Clément Delmas, Anne‐Sophie Simoni, Céline Goeminne, Aude Boignard, Anne‐Céline Martin, Fabrice Vanhuyse, Erwan Flecher, Catherine Nafeh‐Bizet, Romain Itier, Nicolas Pages, Sophie Nisse‐Durgeat, Pascal Battistella, Karine Nubret‐le‐Coniat   +12 more
wiley   +1 more source

Percutaneous Intervention of LVAD Outflow Graft Obstruction and Thrombosis

Methodist DeBakey Cardiovascular Journal
Left ventricular assist devices serve as a salvage therapy for patients with advanced heart failure. Complications such as thrombosis and obstruction can lead to acute device malfunction, posing significant clinical risks. A multidisciplinary approach is
Andrew Takla, Fahad Eid, Mostafa Elbanna, Mohamed Magdi Eid, Akshay Joshi, Abdallah Bitar, Ryan Lydon, Scott Feitell   +7 more
doaj   +1 more source

Hemocompatibility Outcomes After Aspirin Withdrawal in Long‐Term HeartMate 3 Left Ventricular Assist Device Patients on Vitamin K Antagonists

Artificial Organs, EarlyView.
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter, Barbara Karner, Hebe Al Asadi, Christina Abd El‐Malak, Christiane Marko, Daniel Zimpfer, Julia Riebandt, Roxana Moayedifar, Thomas Schlöglhofer   +8 more
wiley   +1 more source

IL-33/ST2 Pathway and Classical Cytokines in End-Stage Heart Failure Patients Submitted to Left Ventricular Assist Device Support: A Paradoxic Role for Inflammatory Mediators?

Mediators of Inflammation, 2013
Background. Inflammation is a critical process contributing to heart failure (HF). We hypothesized that IL-33/ST2 pathway, a new mechanism regulated during cardiac stress, may be involved in the functional worsening of end-stage HF patients, candidates ...
C. Caselli, A. D'Amico, R. Ragusa, R. Caruso, T. Prescimone, M. Cabiati, S. Nonini, P. Marraccini, S. Del Ry, M. G. Trivella, O. Parodi, D. Giannessi   +11 more
doaj   +1 more source

A Novel Biventricular Assist Device With a Single Driveline: A Report on the First Patient Treated

Artificial Organs, EarlyView.
We would like to report the first‐in‐human implantation of the novel DuoCor‐BiVAS biventricular assist device (BiVAD). This system features a single driveline and compact peripheral components, offering a promising mechanical support option for patients with terminal biventricular heart failure ineligible for heart transplantation.
Jan D. Schmitto, Jasmin S. Hanke, Sara Knigge, Zurab Darbaidze, Fanwu Kong, Torsten Heilmann, Alexander Weymann, Günes Dogan, Arjang Ruhparwar   +8 more
wiley   +1 more source

Single‐Incision Anterolateral Thoracotomy for LVAD Implantation: A Novel Minimally Invasive Approach

Artificial Organs, EarlyView.
A novel single‐incision anterolateral thoracotomy technique enables complete HeartMate 3 implantation without sternotomy, minimizing surgical trauma and accelerating recovery. This minimally invasive approach is feasible, safe, and may represent a new standard in advanced heart failure surgery.
Ali Saad Merzah, Günes Dogan, Alina Zubarevich, Stefan Rümke, Bastian Schmack, Ezin Deniz, Jasmin Hanke, Arjang Ruhparwar, Jan D. Schmitto, Alexander Weymann   +9 more
wiley   +1 more source

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Cardiogenic shock (CS) is a complex syndrome associated with high morbidity and mortality. In recent years, many US hospitals have formed multidisciplinary shock teams capable of rapid diagnosis and triage. Because of preexisting collaborative
Joseph I. Wang, Daniel Y. Lu, MHS, Dmitriy N. Feldman, Stephen A. McCullough, Parag Goyal, Maria G. Karas, Irina Sobol, Evelyn M. Horn, Luke K. Kim, Udhay Krishnan   +10 more
doaj   +1 more source